How do Pathologists Determine if Death in Vaccinated Patients is Caused by COVID-19 or Vaccination?

An excerpt from Taylor Hudak’s interview with Prof. Arne Burkhardt.

(Watch the full interview here)

SARS-COV-2 virus particles contain two major proteins — first, the spike protein, which is located at the surface of the virus particle and second, the nucleocapsid protein, which forms a protective layer around the RNA genome.

Therefore, virus-infected cells should make both of these proteins. Meanwhile, the vaccine only encodes the spike protein and not the nucleocapsid protein. This has been experimentally confirmed by German physician Dr. Michael Mörz.

Prof. Arne Burkhardt uses multiple criteria to establish vaccine causation in his own study, including immunohistochemistry (IHC). This method allows for the detection of specific molecules of interest in the tissue samples by using specific antibodies. In this case, the molecules of interest are the spike protein or the nucleocapsid, respectively.

The following is a summary of the IHC technique. The spike protein is used as the example of the molecule of interest.

Immunohistochemistry (IHC) testing method

First, an antibody which interacts with the molecule of interest, in this case the spike protein, is applied to the tissue sample. After allowing some time for the antibody to bind to its target, the unbound surplus is washed off. 

Next, a secondary antibody coupled with a catalytic protein enzyme is applied to the same tissue sample. This second antibody binds to the first one. After some more time the unbound surplus is, again, washed off. 

Third, a colorless, dye precursor, most often diaminobenzidine, is added to the sample. This dye precursor can be converted to an actual dye by the enzyme that is attached to the second antibody, and thus indirectly to the spike protein. 

The brown dye that is produced by the enzyme is insoluble, so it comes out of solution and is deposited close by. Thus, wherever there are deposits of brown pigment, we know that spike protein must have been present. 

The same procedure can be performed separately with an antibody that specifically recognizes the nucleocapsid.

If IHC for the spike protein is positive, but IHC for the nucleocapsid is negative, it is a strong indication that the presence of the spike protein in the tissue sample is caused by the vaccination and not the viral infection.

While detection of spike protein in the absence of the nucleocapsid using IHC clearly points to vaccine causation, Prof. Burkhardt does not rely on this method alone.

“Let me stress this. We never make this diagnosis only dependent on our immunohistochemistry (testing). We only make this diagnosis if we have lesions which are distinctly positive and which by themselves are already absolutely typical of vaccination damage like elastic destruction.”

He states that lesions may occur in locations not commonly infected by the virus, or they may show distinctive features which are not found in the infection. According to him, observations of this kind can provide strong evidence of vaccine causation in addition to IHC, or even without it.

IHC staining of small blood vessels

The following images, which show the cross sections of two small blood vessels, are from a published study by pathologist Dr. Mörz. The samples were tested for the spike protein and nucleocapsid protein using IHC.

“On the top, you see small vessels and already from this magnification these vessels have an endothelial damage. Then you have the brown stain and that means immunohistochemically spike protein can be see here. Below, the same vessels are seen, and they are stained for nucleocapsid. You see the same lesions of the endothelium, but there’s no staining. So this is a very strong indication considering everything that you see, that this is a  specific lesion by the vaccine-produced spike protein and not by the virus-produced spike protein.”

In all of the cases in which there was a positive spike protein reaction, Prof. Burkhardt also tested for the nucleocapsid.

In two or three of the cases, there was a positive reaction for both the spike and nucleocapsid. In these cases, Prof. Burkhardt said there may be an additive effect of the vaccination and the viral infection. In his observation, these patients had the most severe side effects.